Betadex Sulfobutyl Ether Sodium pulveris pro Formulae injectabiles et Parentales, SBECD late in evolutione medicamentorum recentiorum adhibetur, ob singularem facultatem augendi solutionem et bioavailability APIs. Maxime utilis est in formula antivirali, antifungali, anticancri et medicamentis cardiovascularibus.
Betadex Sulfobutyl Ether Sodium pulveris pro Injectable et Parenteral Formulae
Betadex Sulfobutyl Ether Sodium (SBECD) est valde purificatus, non-toxicus; cyclodextrinum anionicum derivativum specifice enucleatum pro medicamento parentali systemata partus, etiam injectabilis, ophthalmicus, et inhalatio formulae.
Solubilitatem, stabilitatem, ac biouabilitatem male comparatorum auget aqua solutum activum medicamentum (APIs), sine toxicity periculum cum traditional solubilizers.
Productum XI'an Deli Co., Ltd USP et EP signis et plus quam 26 annis peritia innititur vestibulum cyclodextrin.
SBECD late in modernis pharmacis evolutionis usu ob singularem suam facultatem emendare API solubilitatem et bioavailability, praesertim in injectabili ac formulae parentum.
Si vis auctoritas, COA vel ordo iudicii, pete nos:
Inscriptio:xadl@xadl.com
Societas:Xi'an Deli Biochemical Industry Co., Ltd.
Betadex Sulfobutyl Ether Sodium CAS NO 182410-00-0
Sulfobutyl Ether Beta Cyclodextrin Sodium
Betadex Sulfobutyl Ether Sodium Iniectio Grade
Betadex Sulfobutyl Ether Sodium SBECD Injectable Gradus ad medicamentis formulae
Betadex Sulfobutyl Ether Sodium CAS 182410-00-0
DMF Betadex Sulfobutyl Ether Sodium 182410-00-0